melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Melanoma in situ of lower limb, including hip
DOID EFO Endpoint Browser PheWeb
CD2_INSITU_MELANOMA_LOWERLIMB
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
281 |
4. Check minimum number of eventsNone |
281 |
5. Include endpointsNone |
281 |
6. Filter based on genotype QC (FinnGen only) |
253 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ coxae
Melanoma in situ of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 253 | 188 | 65 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.03 |
| Median age at first event (years) | 66.34 | 63.77 | 73.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 261
- Matched controls
- 2610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
121.1
310.1
172
41
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
307.7
261
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
41.0
113.0
72
24
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
318.5
89.6
86
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
17.8
85.0
78
61
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.8
72.0
99
140
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.0
59.1
74
91
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
11.6
57.6
68
77
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.0
46.6
133
384
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.9
41.8
67
109
D22
ICD-10 Finland
Melanocytic naevi
9.3
38.9
52
68
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
14.8
37.3
35
27
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
94.1
30.5
33
*
L57.0
ICD-10 Finland
Actinic keratosis
5.2
30.1
78
198
S18
ICPC
Laceration/cut
4.0
23.3
188
1028
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
9.2
22.7
29
35
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
57.5
22.5
26
5
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
125.6
21.9
23
*
TQW99
NOMESCO Finland
Other minor procedure on skin
5.9
21.8
43
84
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
119.6
20.9
22
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
204.1
18.8
19
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
71.8
18.0
20
*
S82
ICPC
Naevus/mole
3.5
16.9
72
255
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.6
16.8
45
114
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
50.9
16.3
19
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
15.6
50
145
TQW40, ,
SPAT
3.8
15.4
55
172
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
14.7
14
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
79.4
13.7
15
*
ZZR00
NOMESCO Finland
Flap of skin
10.9
12.3
23
23
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.2
12.2
26
54
C43
ICD-10 Finland
Malignant melanoma of skin
49.1
12.0
14
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
31.7
11.8
15
5
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
125.3
11.5
12
*
S77
ICPC
Malignant neoplasm of skin
18.1
11.4
17
10
L82
ICD-10 Finland
Seborrhoeic keratosis
2.7
11.3
81
377
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
14.8
11.1
18
13
XQ848
NOMESCO Finland
Dermatological photography
5.8
11.1
21
39
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
10.5
10
*
ZZA00
NOMESCO Finland
Split skin graft
8.0
10.4
23
31
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
14.1
9.8
16
12
XQ845
NOMESCO Finland
Dermatoscopy
9.7
9.7
19
21
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
10.6
9.7
18
18
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
31.3
9.5
12
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
22.7
9.4
13
6
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
9.4
9
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
9.6
9.2
18
20
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
19.5
9.0
13
7
ZXC50
NOMESCO Finland
Cryotherapy
5.0
9.0
20
43
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.3
8.1
33
111
TQW11
NOMESCO Finland
Vacuum treatment of wound
9.3
7.7
15
17
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
25.9
7.6
10
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
25.9
7.6
10
*
D03
ICD-10 Finland
Melanoma in situ
+∞
7.3
7
*
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
12.5
7.2
12
10
SPAT1153
SPAT
Removal of sutures
2.1
7.1
102
621
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
7.9
7.0
15
20
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.2
6.8
76
418
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.8
6.7
18
33
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
6.5
6.6
16
26
D06BB10
ATC
imiquimod; topical
3.5
6.4
23
71
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
18.6
6.3
9
5
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
18.6
6.3
9
5
ZXC20
NOMESCO Finland
Use of chemical agents
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
40
209
2.08
4.00
4.2
3.6
94.24
77.43
ng/l
0.51
34
182
247
2245
2.87
3.89
20.3
15.9
76.94
78.49
ml/min/173m2
0.65
236
2094
17
62
2.86
3.66
1.4
1.2
—
—
—
0
0
60
374
1.78
3.55
4.2
3.1
1.78
2.37
e6/l
0.31
26
175
13
39
3.45
3.27
1.6
1.5
—
—
—
0
0
13
39
3.45
3.27
1.6
1.5
—
—
—
0
0
64
422
1.68
3.08
4.3
2.9
0.46
0.85
e6/l
1.50
30
219
12
37
3.35
2.97
1.1
1.5
—
—
—
0
0
102
767
1.54
2.83
1.9
2.1
129.01
275.14
u/l
0.88
97
729
17
72
2.46
2.79
1.2
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
6
8.46
2.76
1.0
1.0
99.40
146.33
%
—
5
6
36
580
0.56
2.69
5.5
4.0
1.02
1.02
kg/l
0.13
27
383
244
2262
2.21
2.65
5.4
5.4
5.72
5.91
mmol/l
2.60
222
2078
249
2330
2.49
2.59
6.2
6.2
2.66
2.71
mmol/l
0.47
228
2149
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
7
7.25
2.56
1.4
1.0
120.00
122.57
%
—
5
7
239
2205
2.00
2.54
6.6
6.6
38.32
39.24
mmol/mol
1.33
222
2070
245
2294
2.11
2.26
5.2
5.4
4.61
4.70
mmol/l
0.75
226
2121
16
73
2.27
2.26
1.1
1.2
—
—
—
0
0
5
9
5.64
2.22
1.0
2.0
109.40
107.56
%
—
5
9
250
2363
2.38
2.18
21.6
19.0
3.95
3.97
mmol/l
0.30
243
2315
137
1140
1.42
2.12
2.9
2.5
85.21
78.96
nmol/l
1.87
129
1025
6
15
4.07
2.05
2.2
1.6
9.43
13.60
umol/l
—
6
15
42
276
1.62
2.04
4.0
3.0
0.72
0.77
ug/l
0.27
35
191
243
2283
1.93
1.99
5.2
5.2
1.56
1.54
mmol/l
0.26
225
2098
243
2292
1.87
1.82
18.1
15.9
21.06
22.74
mg/l
0.34
192
1866
200
1806
1.46
1.81
4.8
4.6
10.29
12.52
mm/h
1.67
187
1666
73
555
1.44
1.81
3.5
1.7
4.29
1.31
mg/l
0.50
49
457
16
82
2.01
1.73
3.6
1.6
486.31
734.22
ug/l
0.17
16
76
248
2361
2.01
1.70
21.0
18.9
139.93
139.79
mmol/l
0.41
241
2321
75
590
1.38
1.51
2.4
2.2
—
—
—
0
0
82
1001
0.74
1.49
3.8
3.8
0.05
0.01
estimate
0.31
19
213
12
59
2.08
1.46
1.3
1.5
—
—
—
0
0
146
1276
1.33
1.45
6.7
7.0
1.24
1.22
mmol/l
4.29
128
1114
31
208
1.56
1.41
2.0
2.2
3.05
3.22
ratio
0.40
24
170
19
112
1.75
1.39
1.2
1.3
—
—
—
0
0
34
234
1.52
1.38
1.9
2.9
65.07
66.78
g/l
0.71
29
219
43
311
1.46
1.38
5.0
5.1
33.77
33.09
%
0.13
30
193
34
236
1.51
1.33
1.9
2.3
28.48
33.81
u/l
0.62
29
194
12
216
0.53
1.32
1.6
2.4
0.00
0.20
e6/l
3.99
12
205
156
1389
1.31
1.30
11.2
10.1
4.01
3.93
e9/l
0.19
133
1217
5
18
2.81
1.29
1.4
1.2
385.80
259.62
mu/l
—
5
13
19
115
1.70
1.29
2.1
2.3
3.15
2.98
g/l
0.37
14
108
23
147
1.62
1.28
1.8
1.8
—
—
—
0
0
150
1333
1.29
1.25
2.7
2.9
—
—
—
0
0
77
626
1.33
1.24
2.8
2.8
346.50
336.03
umol/l
0.34
66
540
8
38
2.14
1.19
1.6
1.2
—
—
—
0
0
131
1151
1.28
1.16
6.9
6.1
1.23
1.22
mmol/l
1.33
123
1063
229
2171
1.45
1.15
4.3
4.4
1.25
1.26
mmol/l
0.12
207
1984
12
65
1.89
1.15
2.7
3.2
1.71
1.52
index
—
7
40
122
1066
1.27
1.12
2.0
1.9
1.27
1.33
mmol/l
0.57
104
893
19
120
1.63
1.12
1.1
1.1
—
—
—
0
0
231
2196
1.45
1.12
6.4
5.8
1.84
1.91
mu/l
0.53
214
2016
126
1108
1.27
1.09
4.7
4.6
36.65
35.83
g/l
1.01
118
1038
16
97
1.69
1.09
2.6
1.5
—
—
—
0
0
167
1522
1.27
1.06
3.5
3.3
41.01
45.85
u/l
0.39
152
1434
11
60
1.87
1.04
1.0
1.4
—
—
—
0
0
11
60
1.87
1.04
1.1
1.4
448.20
24163.72
e6/l
—
5
40
81
683
1.27
0.98
5.1
3.2
0.38
0.40
e6/l
0.05
53
493
0
30
0.00
0.98
0.0
1.1
—
7.27
—
0
23
199
1862
1.29
0.97
9.9
8.2
74.65
77.04
u/l
0.63
192
1754
12
71
1.72
0.90
1.3
1.1
—
6.48
—
0
8
46
364
1.32
0.90
5.2
4.9
20.87
21.44
%
0.13
33
189
6
30
2.02
0.87
1.0
1.4
—
—
—
0
0
56
459
1.28
0.85
7.3
5.9
2.72
2.80
ug/l
0.04
47
408
23
164
1.44
0.83
1.9
2.0
3.08
3.35
mmol/l
0.43
16
126
0
24
0.00
0.79
0.0
1.0
—
591.22
—
0
18
0
24
0.00
0.79
0.0
1.1
—
39.91
—
0
17
57
476
1.25
0.75
3.7
3.7
56.64
266.29
ng/l
1.47
45
371
39
477
0.79
0.68
1.3
1.3
8.65
13.53
u/ml
0.33
13
183
102
915
1.19
0.66
4.5
3.4
2.35
2.36
mmol/l
0.28
95
831
13
87
1.52
0.64
1.2
1.5
—
—
—
0
0
28
352
0.77
0.61
4.9
6.7
103.96
104.14
mmol/l
0.09
28
352
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
17
230
0.72
0.60
3.9
2.7
4.13
4.23
kpa
0.08
17
225
8
52
1.56
0.60
4.1
2.5
6.63
10.18
pmol/l
—
8
52
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
19
142
1.36
0.56
5.0
3.2
24.78
24.42
mmol/l
0.37
19
142
20
151
1.35
0.56
5.5
7.2
24.97
24.98
mmol/l
0.01
20
151
66
747
0.84
0.54
4.1
3.9
0.00
0.01
estimate
0.50
22
245
36
297
1.25
0.54
2.0
1.9
—
—
—
0
0
198
1895
1.19
0.54
5.0
4.6
14.93
14.82
pmol/l
0.28
185
1727
6
39
1.55
0.53
1.8
1.4
43.22
37.78
u/l
—
6
32
34
408
0.81
0.51
1.8
1.5
—
—
—
0
0
44
513
0.83
0.50
1.5
1.3
33.69
36.21
iu/ml
0.06
12
162
21
163
1.31
0.50
1.1
1.2
138.02
161.06
u/ml
—
8
75
51
441
1.19
0.49
1.5
1.5
—
—
—
0
0
85
768
1.16
0.49
1.9
1.7
25.13
21.31
nmol/l
1.46
69
645
33
273
1.24
0.49
1.6
2.7
4.63
6.11
umol/l
1.44
25
239
5
84
0.59
0.46
1.8
1.8
—
—
—
0
0
21
262
0.78
0.45
4.6
3.4
6.07
5.69
kpa
1.77
21
257
45
391
1.18
0.42
2.0
2.0
—
—
—
0
0
8
58
1.39
0.42
1.3
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
26
214
1.24
0.41
1.5
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
3.6
—
0.81
—
0
16
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
11
80
1.39
0.39
2.5
1.2
—
—
—
0
0
119
1116
1.12
0.38
2.4
2.2
98.91
97.84
pmol/l
0.08
53
571
29
244
1.21
0.38
3.8
3.4
—
—
—
0
0
5
36
1.40
0.38
3.8
1.3
—
—
—
0
0
5
36
1.40
0.38
3.8
1.3
—
—
—
0
0
5
36
1.40
0.38
3.8
1.2
—
—
—
0
0
22
180
1.24
0.37
3.9
3.1
18.23
38.95
u/ml
1.51
22
173
5
37
1.36
0.37
3.8
1.2
—
—
—
0
0
5
37
1.36
0.37
3.8
1.2
—
—
—
0
0
5
37
1.36
0.37
1.0
1.4
—
—
—
0
0
5
37
1.36
0.37
3.8
1.2
—
—
—
0
0
88
946
0.89
0.34
3.4
4.0
28.60
72.59
ng/l
0.64
59
701
6
45
1.34
0.34
1.0
1.1
—
11.81
—
0
11
148
1415
1.11
0.32
4.5
4.8
6.28
6.60
mmol/l
1.21
133
1345
21
250
0.83
0.31
4.6
3.4
2.16
1.80
mmol/l
0.29
21
217
66
718
0.89
0.31
2.7
3.4
0.00
0.12
estimate
0.50
21
213
32
278
1.17
0.31
2.1
2.0
—
—
—
0
0
21
175
1.22
0.31
2.5
1.4
—
—
—
0
0
121
1147
1.10
0.31
3.3
3.0
117.86
110.74
ug/l
0.20
113
1069
10
75
1.35
0.30
1.4
1.4
—
—
—
0
0
16
195
0.81
0.30
3.3
2.7
63.40
63.92
ml/min/173m2
—
5
85
7
56
1.26
0.29
1.1
1.5
—
—
—
0
0
10
76
1.33
0.28
1.5
1.3
—
—
—
0
0
32
282
1.15
0.27
4.8
6.8
—
—
—
0
0
68
634
1.10
0.24
2.4
2.2
2.20
3.07
mg/l
4.11
58
554
41
373
1.12
0.22
3.9
2.4
24.43
22.49
%
0.53
36
351
5
40
1.25
0.22
1.0
1.1
—
1.62
—
0
9
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
26.54
—
0
10
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
46
423
1.11
0.21
3.7
2.4
13.22
13.25
umol/l
0.01
39
396
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
116
1114
1.07
0.20
2.7
2.6
—
—
estimate
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
11
90
1.23
0.19
2.1
4.3
1.17
2.88
ratio
—
6
46
5
68
0.73
0.17
1.0
1.8
—
—
—
0
0
5
70
0.71
0.17
1.2
1.7
—
—
—
0
0
19
168
1.14
0.16
1.5
1.8
—
—
—
0
0
9
80
1.13
0.15
1.6
1.2
—
—
—
0
0
13
150
0.86
0.15
3.2
2.5
0.62
0.61
%
0.04
13
150
87
838
1.06
0.13
5.3
4.0
8.19
8.85
mg/mmol
0.06
48
484
42
396
1.07
0.12
3.8
2.4
2.15
2.31
g/l
1.38
36
363
5
62
0.80
0.08
2.2
1.2
—
—
—
0
0
17
156
1.10
0.08
1.4
1.7
—
—
—
0
0
7
64
1.10
0.08
6.4
3.5
14.86
27.90
u/ml
—
7
64
6
70
0.85
0.07
1.7
1.2
0.99
0.89
g/l
—
6
70
6
70
0.85
0.07
1.0
1.6
—
—
—
0
0
6
74
0.81
0.07
1.0
1.6
—
—
—
0
0
85
829
1.04
0.07
2.8
3.0
25.91
29.97
u/l
1.55
77
785
14
153
0.91
0.07
2.8
2.5
1.07
1.16
%
0.16
14
153
15
163
0.92
0.07
4.9
9.6
94.10
93.95
%
0.03
15
163
8
94
0.85
0.07
1.6
2.6
—
—
—
0
0
14
129
1.09
0.05
1.2
1.3
—
—
—
0
0
81
793
1.03
0.05
4.0
3.3
909.04
1123.60
ng/l
0.48
70
676
130
1316
0.98
0.05
4.1
4.0
0.00
6.06
estimate
0.50
28
268
10
91
1.10
0.04
1.4
1.8
—
—
—
0
0
50
512
0.97
0.03
1.6
1.8
517.98
466.72
pmol/l
0.53
40
432
58
590
0.98
0.02
1.3
1.3
1.61
1.49
u/ml
0.05
11
163
28
286
0.98
0.00
3.7
7.6
5.25
5.11
kpa
0.50
28
278
28
286
0.98
0.00
3.7
7.6
12.45
11.98
kpa
0.18
28
278
131
1306
1.01
0.00
4.0
3.9
0.00
0.00
estimate
-0.00
25
257
133
1335
0.99
0.00
4.1
4.0
0.00
1.20
estimate
0.50
27
249
7
73
0.96
-0.00
2.4
1.5
—
0.07
—
0
11
0
7
0.00
-0.00
0.0
5.7
—
207.86
—
0
7
8
85
0.94
-0.00
1.4
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
49.84
—
0
9
0
8
0.00
-0.00
0.0
3.8
—
43.31
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
7.38
—
0
6
44
440
1.00
-0.00
1.8
1.7
1155.67
1199.11
nmol/l
0.08
24
334
0
6
0.00
-0.00
0.0
1.2
—
9.17
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
66
0.91
-0.00
1.7
1.2
1.68
1.59
g/l
—
6
66
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB – Melanoma in situ of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).